Myriad Pharma posts smaller 1Q loss after spinoff

Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal first-quarter loss on lower research costs after the company was spun off from Myriad Genetics Inc.

0

0

A federal judge ruled Monday that a lawsuit can move forward against the Patent and Trademark Office and the research company that was awarded exclusive rights to human genes known to detect early signs of breast and ovarian cancer. More Articles

13

13

The American Civil Liberties Union is suing the Patent and Trademark Office and a research company awarded exclusive rights to human genes known to detect early signs of breast or ovarian cancer. The group claims the patents violate speech by restricting research.

3

4

Here's a little-known fact: Under current law, it's possible to hold a patent on a piece of human DNA, otherwise known as a gene. More Articles

19

30

Current Flurizan™ Phase 3 Study Design May Demonstrate Disease Modification (Alzheimer's)

0

0

A heated response to the BRCA controversy of yesterday.

0

0